CABALETTA BIO, INC. (CABA): Price and Financial Metrics
CABA Price/Volume Stats
| Current price | $2.74 | 52-week high | $26.35 |
| Prev. close | $2.43 | 52-week low | $1.76 |
| Day low | $2.38 | Volume | 3,037,800 |
| Day high | $2.85 | Avg. volume | 1,650,091 |
| 50-day MA | $2.91 | Dividend yield | N/A |
| 200-day MA | $6.80 | Market Cap | 133.92M |
CABA Stock Price Chart Interactive Chart >
CABALETTA BIO, INC. (CABA) Company Bio
Cabaletta Bio, Inc. operates as a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies. The company was founded by Michael C. Milone, Steven Nichtberger, and Aimee Payne in 2017 and is headquartered in Philadelphia, PA.
CABA Price Returns
| 1-mo | 15.13% |
| 3-mo | -32.01% |
| 6-mo | -59.41% |
| 1-year | -86.61% |
| 3-year | -3.86% |
| 5-year | -84.02% |
| YTD | 20.70% |
| 2024 | -90.00% |
| 2023 | 145.41% |
| 2022 | 144.06% |
| 2021 | -69.63% |
| 2020 | -10.67% |
Loading social stream, please wait...